Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review

Detalhes bibliográficos
Autor(a) principal: Grota, Aline Joelma de Almeida
Data de Publicação: 2021
Outros Autores: Silva, Daniele Cordovil da, Figueiredo, Geusabina Trindade de Oliveira, Castro, Rosângela da Silva
Tipo de documento: Artigo
Idioma: por
Título da fonte: Research, Society and Development
Texto Completo: https://rsdjournal.org/index.php/rsd/article/view/22087
Resumo: Introduction: Type 2 Diabetes mellitus (DM 2) develops when insulin secretion is inadequate to meet the growing needs that arise with insulin resistance. Objective: To highlight the importance of the pharmacist in monitoring the treatment of patients with type 2 Diabetes Mellitus. Methods: This is a systematic review of online and printed databases, books, theses, dissertations and articles using descriptors combined or not: "Diabetes Mellitus type 2", "pharmaceutical consultation", "pharmaceutical treatment of type 2 DM", "pharmacotherapeutic monitoring" and "Diabetes Mellitus type 2", "pharma consulting", "pharmacological treatment of DM type 2”, “pharmacotherapeutic pharmacopoeia” performed in virtual libraries Medline, Lilacs, Pubmed, Scielo and BVS. Results: 32 articles were selected to compose the systematic review and bibliography used here. Appropriate treatment and management of chronic diseases (hypertension, Diabetes Mellitus type 2, dyslipidemia, etc.) in primary medical institutions has been identified as the main cause of the increase in medical expenses. In Brazil, according to recent data, it appears that the number of adults has increased rapidly, which in theory highlights that Diabetes Mellitus is a chronic disease with greater probability of occurring during the transition from poverty to abundance. Conclusions: Diabetes is expected to become one of the main diseases of adults in Brazil and to remain a public health problem in the world for a considerable period of time in the future.
id UNIFEI_2c572b4fc4cfc3ee79f639f1f5900ab2
oai_identifier_str oai:ojs.pkp.sfu.ca:article/22087
network_acronym_str UNIFEI
network_name_str Research, Society and Development
repository_id_str
spelling Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic reviewConsulta y diagnóstico farmacéutico de Diabetes Mellitus tipo 2: revisión sistemáticaConsulta e diagnóstico farmacêutico da Diabetes Mellitus tipo 2: uma revisão sistemáticaFarmacèutico; FarmacêuticoDiabetes Mellitus tipo 2Diabetes Mellitus; Diagnóstico Farmacêutico;Diagnóstico farmacêutico.PharmacistType 2 Diabetes MellitusPharmaceutical diagnosis.FarmacéuticoDiabetes Mellitus Tipo 2Diagnóstico farmacéutico.Introduction: Type 2 Diabetes mellitus (DM 2) develops when insulin secretion is inadequate to meet the growing needs that arise with insulin resistance. Objective: To highlight the importance of the pharmacist in monitoring the treatment of patients with type 2 Diabetes Mellitus. Methods: This is a systematic review of online and printed databases, books, theses, dissertations and articles using descriptors combined or not: "Diabetes Mellitus type 2", "pharmaceutical consultation", "pharmaceutical treatment of type 2 DM", "pharmacotherapeutic monitoring" and "Diabetes Mellitus type 2", "pharma consulting", "pharmacological treatment of DM type 2”, “pharmacotherapeutic pharmacopoeia” performed in virtual libraries Medline, Lilacs, Pubmed, Scielo and BVS. Results: 32 articles were selected to compose the systematic review and bibliography used here. Appropriate treatment and management of chronic diseases (hypertension, Diabetes Mellitus type 2, dyslipidemia, etc.) in primary medical institutions has been identified as the main cause of the increase in medical expenses. In Brazil, according to recent data, it appears that the number of adults has increased rapidly, which in theory highlights that Diabetes Mellitus is a chronic disease with greater probability of occurring during the transition from poverty to abundance. Conclusions: Diabetes is expected to become one of the main diseases of adults in Brazil and to remain a public health problem in the world for a considerable period of time in the future.Introducción: La Diabetes mellitus tipo 2 (DM 2) se desarrolla cuando la secreción de insulina es inadecuada para satisfacer las crecientes necesidades que surgen con la resistencia a la insulina. Objetivo: Resaltar la importancia del farmacéutico en el seguimiento del tratamiento de pacientes con Diabetes Mellitus tipo 2. Métodos: Se trata de una revisión sistemática de bases de datos impresas y en línea, libros, tesis, disertaciones y artículos utilizando descriptores combinados o no: "Diabetes Mellitus tipo 2 "," consulta farmacéutica "," tratamiento farmacéutico de DM tipo 2 "," monitorización farmacoterapéutica "y" Diabetes Mellitus tipo 2 "," consulta farmacéutica "," tratamiento farmacológico de DM tipo 2 "," farmacopea farmacoterapéutica "realizada en bibliotecas virtuales Medline, Lilacs, Pubmed, Scielo y BVS. RESULTADOS: Se seleccionaron 32 artículos para componer la revisión sistemática y bibliografía aquí utilizada. El tratamiento y manejo adecuado de las enfermedades crónicas (hipertensión, Diabetes Mellitus tipo 2, dislipidemias, etc.) en las instituciones de atención primaria se ha identificado como la principal causa del aumento de los gastos médicos. En Brasil, según datos recientes, parece que el número de adultos ha aumentado rápidamente, lo que en teoría destaca que la Diabetes Mellitus es una enfermedad crónica con mayor probabilidad de ocurrir durante la transición de la pobreza a la abundancia. Conclusiones: Se espera que la diabetes se convierta en una de las principales enfermedades de los adultos en Brasil y siga siendo un problema de salud pública en el mundo durante un período de tiempo considerable en el futuro.Introdução: Diabetes mellitus tipo 2 (DM 2) se desenvolve quando a secreção de insulina é inadequada para atender às necessidades crescentes que surgem com a resistência à insulina. Objetivo: Destacar a importância do farmacêutico no acompanhamento de tratamento do paciente com Diabetes Mellitus do tipo 2. Métodos: Trata-se de uma revisão sistemática em bancos de dados on line e impressos, em livros, teses, dissertações e artigos por meio dos descritores combinados entre si ou não: “Diabetes Mellitus tipo 2”, “consulta farmacêutica”, “tratamento farmacêutico de DM tipo 2”, “acompanhamento farmacoterapêutico” e “Diabetes Mellitus type 2”, “pharma consulting”, “pharmacological treatment of DM type 2”, “pharmacotherapeutic pharmacopoeia” realizado em bibliotecas virtuais Medline, Lilacs, Pubmed, Scielo e BVS. Resultados: Foram selecionados 32 artigos para compor a revisão sistemática e a bibliografia aqui utilizadas. Identificou-se que o tratamento e gerenciamento adequados de doenças crônicas (hipertensão, Diabetes Mellitus tipo 2, dislipidemia, etc.) em instituições médicas primárias é a principal causa do aumento nas despesas médicas. No Brasil, de acordo com dados recentes, verifica-se que o número de adultos aumentou rapidamente na qual em tese destaca-se que a Diabetes Mellitus é uma doença crônica com maior probabilidade de ocorrer durante a transição da pobreza para a abundância. Conclusões: Espera-se que o diabetes se torne uma das principais doenças dos adultos no Brasil e continue sendo um problema de saúde pública no mundo por um período considerável no futuro.Research, Society and Development2021-10-30info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://rsdjournal.org/index.php/rsd/article/view/2208710.33448/rsd-v10i14.22087Research, Society and Development; Vol. 10 No. 14; e181101422087Research, Society and Development; Vol. 10 Núm. 14; e181101422087Research, Society and Development; v. 10 n. 14; e1811014220872525-3409reponame:Research, Society and Developmentinstname:Universidade Federal de Itajubá (UNIFEI)instacron:UNIFEIporhttps://rsdjournal.org/index.php/rsd/article/view/22087/19477Copyright (c) 2021 Aline Joelma de Almeida Grota; Daniele Cordovil da Silva; Geusabina Trindade de Oliveira Figueiredo; Rosângela da Silva Castrohttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessGrota, Aline Joelma de Almeida Silva, Daniele Cordovil daFigueiredo, Geusabina Trindade de OliveiraCastro, Rosângela da Silva 2021-12-04T11:48:39Zoai:ojs.pkp.sfu.ca:article/22087Revistahttps://rsdjournal.org/index.php/rsd/indexPUBhttps://rsdjournal.org/index.php/rsd/oairsd.articles@gmail.com2525-34092525-3409opendoar:2024-01-17T09:41:21.050192Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)false
dc.title.none.fl_str_mv Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
Consulta y diagnóstico farmacéutico de Diabetes Mellitus tipo 2: revisión sistemática
Consulta e diagnóstico farmacêutico da Diabetes Mellitus tipo 2: uma revisão sistemática
title Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
spellingShingle Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
Grota, Aline Joelma de Almeida
Farmacèutico;
Farmacêutico
Diabetes Mellitus tipo 2
Diabetes Mellitus; Diagnóstico Farmacêutico;
Diagnóstico farmacêutico.
Pharmacist
Type 2 Diabetes Mellitus
Pharmaceutical diagnosis.
Farmacéutico
Diabetes Mellitus Tipo 2
Diagnóstico farmacéutico.
title_short Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
title_full Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
title_fullStr Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
title_full_unstemmed Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
title_sort Consultation and pharmaceutical diagnosis of Diabetes Mellitus type 2: a systematic review
author Grota, Aline Joelma de Almeida
author_facet Grota, Aline Joelma de Almeida
Silva, Daniele Cordovil da
Figueiredo, Geusabina Trindade de Oliveira
Castro, Rosângela da Silva
author_role author
author2 Silva, Daniele Cordovil da
Figueiredo, Geusabina Trindade de Oliveira
Castro, Rosângela da Silva
author2_role author
author
author
dc.contributor.author.fl_str_mv Grota, Aline Joelma de Almeida
Silva, Daniele Cordovil da
Figueiredo, Geusabina Trindade de Oliveira
Castro, Rosângela da Silva
dc.subject.por.fl_str_mv Farmacèutico;
Farmacêutico
Diabetes Mellitus tipo 2
Diabetes Mellitus; Diagnóstico Farmacêutico;
Diagnóstico farmacêutico.
Pharmacist
Type 2 Diabetes Mellitus
Pharmaceutical diagnosis.
Farmacéutico
Diabetes Mellitus Tipo 2
Diagnóstico farmacéutico.
topic Farmacèutico;
Farmacêutico
Diabetes Mellitus tipo 2
Diabetes Mellitus; Diagnóstico Farmacêutico;
Diagnóstico farmacêutico.
Pharmacist
Type 2 Diabetes Mellitus
Pharmaceutical diagnosis.
Farmacéutico
Diabetes Mellitus Tipo 2
Diagnóstico farmacéutico.
description Introduction: Type 2 Diabetes mellitus (DM 2) develops when insulin secretion is inadequate to meet the growing needs that arise with insulin resistance. Objective: To highlight the importance of the pharmacist in monitoring the treatment of patients with type 2 Diabetes Mellitus. Methods: This is a systematic review of online and printed databases, books, theses, dissertations and articles using descriptors combined or not: "Diabetes Mellitus type 2", "pharmaceutical consultation", "pharmaceutical treatment of type 2 DM", "pharmacotherapeutic monitoring" and "Diabetes Mellitus type 2", "pharma consulting", "pharmacological treatment of DM type 2”, “pharmacotherapeutic pharmacopoeia” performed in virtual libraries Medline, Lilacs, Pubmed, Scielo and BVS. Results: 32 articles were selected to compose the systematic review and bibliography used here. Appropriate treatment and management of chronic diseases (hypertension, Diabetes Mellitus type 2, dyslipidemia, etc.) in primary medical institutions has been identified as the main cause of the increase in medical expenses. In Brazil, according to recent data, it appears that the number of adults has increased rapidly, which in theory highlights that Diabetes Mellitus is a chronic disease with greater probability of occurring during the transition from poverty to abundance. Conclusions: Diabetes is expected to become one of the main diseases of adults in Brazil and to remain a public health problem in the world for a considerable period of time in the future.
publishDate 2021
dc.date.none.fl_str_mv 2021-10-30
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22087
10.33448/rsd-v10i14.22087
url https://rsdjournal.org/index.php/rsd/article/view/22087
identifier_str_mv 10.33448/rsd-v10i14.22087
dc.language.iso.fl_str_mv por
language por
dc.relation.none.fl_str_mv https://rsdjournal.org/index.php/rsd/article/view/22087/19477
dc.rights.driver.fl_str_mv https://creativecommons.org/licenses/by/4.0
info:eu-repo/semantics/openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/4.0
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Research, Society and Development
publisher.none.fl_str_mv Research, Society and Development
dc.source.none.fl_str_mv Research, Society and Development; Vol. 10 No. 14; e181101422087
Research, Society and Development; Vol. 10 Núm. 14; e181101422087
Research, Society and Development; v. 10 n. 14; e181101422087
2525-3409
reponame:Research, Society and Development
instname:Universidade Federal de Itajubá (UNIFEI)
instacron:UNIFEI
instname_str Universidade Federal de Itajubá (UNIFEI)
instacron_str UNIFEI
institution UNIFEI
reponame_str Research, Society and Development
collection Research, Society and Development
repository.name.fl_str_mv Research, Society and Development - Universidade Federal de Itajubá (UNIFEI)
repository.mail.fl_str_mv rsd.articles@gmail.com
_version_ 1797052694415802368